The DOI matches its Crossref record; 113 of the 113 references it cites were found in a registry or an index.
Recombinant protein vaccines, a proven approach against coronavirus pandemics
Open accessAbstract
With the COVID-19 pandemic now ongoing for close to a year, people all over the world are still waiting for a vaccine to become available. The initial focus of accelerated global research and development efforts to bring a vaccine to market as soon as possible was on novel platform technologies that promised speed but had limited history in the clinic. In contrast, recombinant protein vaccines, with numerous examples in the clinic for many years, missed out on the early wave of investments from government and industry. Emerging data are now surfacing suggesting that recombinant protein vaccines indeed might offer an advantage or complement to the nucleic acid or viral vector vaccines that will likely reach the clinic faster. Here, we summarize the current public information on the nature and on the development status of recombinant subunit antigens and adjuvants targeting SARS-CoV-2 infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Pushko, P., Pumpens, P., & Grens, E. (2013) · Intervirology · doi:10.1159/000346773 · Cited by 5,950
Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2
Yan, R., Zhang, Y., Li, Y., Xia, L., Guo, Y., & Zhou, Q. (2020) · Science · doi:10.1126/science.abb2762 · Cited by 5,040
An mRNA Vaccine against SARS-CoV-2 — Preliminary Report
Jackson, L. A., Anderson, E. J., Rouphael, N. G., Roberts, P. C., Makhene, M., Coler, R. N., McCullough, M. P., Chappell, J. D., Denison, M. R., Stevens, L. J., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2022483 · Cited by 3,406
RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study
Walsh, E. E., Frenck, R., Falsey, A. R., Kitchin, N., Absalon, J., Gurtman, A., Lockhart, S., Neuzil, K., Mulligan, M. J., Bailey, R., et al. (2020) · doi:10.1101/2020.08.17.20176651 · Cited by 2,615
Recombinant protein expression in Escherichia coli: advances and challenges
Rosano, G. L., & Ceccarelli, E. A. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00172 · Cited by 2,556
Folegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China
Wu, A., Peng, Y., Huang, B., Ding, X., Wang, X., Niu, P., Meng, J., Zhu, Z., Zhang, Z., Wang, J., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.02.001 · Cited by 2,361
Tai, W., He, L., Zhang, X., Pu, J., Voronin, D., Jiang, S., Zhou, Y., & Du, L. (2020) · Cellular & Molecular Immunology · doi:10.1038/s41423-020-0400-4 · Cited by 1,654
Okba, N. M. A., Müller, M. A., Li, W., Wang, C., GeurtsvanKessel, C. H., Corman, V. M., Lamers, M. M., Sikkema, R. S., de Bruin, E., Chandler, F. D., et al. (2020) · Emerging Infectious Diseases · doi:10.3201/eid2607.200841 · Cited by 1,614
Profiling Early Humoral Response to Diagnose Novel Coronavirus Disease (COVID-19)
Guo, L., Ren, L., Yang, S., Xiao, M., Chang, D., Yang, F., Dela Cruz, C. S., Wang, Y., Wu, C., Xiao, Y., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa310 · Cited by 1,587
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Liu, L., Wang, P., Nair, M. S., Yu, J., Rapp, M., Wang, Q., Luo, Y., Chan, J. F.-W., Sahi, V., Figueroa, A., et al. (2020) · Nature · doi:10.1038/s41586-020-2571-7 · Cited by 1,349
Laboratory Diagnosis of COVID-19: Current Issues and Challenges
Tang, Y.-W., Schmitz, J. E., Persing, D. H., & Stratton, C. W. (2020) · Journal of Clinical Microbiology · doi:10.1128/jcm.00512-20 · Cited by 1,232
Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine
Keech, C., Albert, G., Cho, I., Robertson, A., Reed, P., Neal, S., Plested, J. S., Zhu, M., Cloney-Clark, S., Zhou, H., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2026920 · Cited by 1,156
Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen
Pallesen, J., Wang, N., Corbett, K. S., Wrapp, D., Kirchdoerfer, R. N., Turner, H. L., Cottrell, C. A., Becker, M. M., Wang, L., Shi, W., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1707304114 · Cited by 1,073
Immunological considerations for COVID-19 vaccine strategies
Jeyanathan, M., Afkhami, S., Smaill, F., Miller, M. S., Lichty, B. D., & Xing, Z. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-00434-6 · Cited by 1,015
Baculovirus as versatile vectors for protein expression in insect and mammalian cells
Kost, T. A., Condreay, J. P., & Jarvis, D. L. (2005) · Nature Biotechnology · doi:10.1038/nbt1095 · Cited by 1,014
Trends in the Development of Baculovirus Expression Vectors
Luckow, V. A., & Summers, M. D. (1988) · Nature Biotechnology · doi:10.1038/nbt0188-47 · Cited by 1,012
Production of human beta interferon in insect cells infected with a baculovirus expression vector.
Smith, G. E., Summers, M. D., & Fraser, M. J. (1983) · Molecular and Cellular Biology · doi:10.1128/mcb.3.12.2156 · Cited by 968
Synthesis and assembly of hepatitis B virus surface antigen particles in yeast
Valenzuela, P., Medina, A., Rutter, W. J., Ammerer, G., & Hall, B. D. (1982) · Nature · doi:10.1038/298347a0 · Cited by 877
A vaccine targeting the RBD of the S protein of SARS-CoV-2 induces protective immunity
Yang, J., Wang, W., Chen, Z., Lu, S., Yang, F., Bi, Z., Bao, L., Mo, F., Li, X., Huang, Y., et al. (2020) · Nature · doi:10.1038/s41586-020-2599-8 · Cited by 780
ter Meulen, J., van den Brink, E. N., Poon, L. L. M., Marissen, W. E., Leung, C. S. W., Cox, F., Cheung, C. Y., Bakker, A. Q., Bogaards, J. A., van Deventer, E., et al. (2006) · PLoS Medicine · doi:10.1371/journal.pmed.0030237 · Cited by 612
SARS-CoV-2-derived peptides define heterologous and COVID-19-induced T cell recognition
Nelde, A., Bilich, T., Heitmann, J. S., Maringer, Y., Salih, H. R., Roerden, M., Lübke, M., Bauer, J., Rieth, J., Wacker, M., et al. (2021) · Nature Immunology · doi:10.1038/s41590-020-00808-x · Cited by 582
Tripathi, N. K., & Shrivastava, A. (2019) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2019.00420 · Cited by 575
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035421 · Cited by 561
Fundamentals and Applications of Controlled Release Drug Delivery
(2012) · Springer eBooks · doi:10.1007/978-1-4614-0881-9 · Cited by 521
Survey of the prevalence of immunization non-compliance due to needle fears in children and adults
Taddio, A., Ipp, M., Thivakaran, S., Jamal, A., Parikh, C., Smart, S., Sovran, J., Stephens, D., & Katz, J. (2012) · Vaccine · doi:10.1016/j.vaccine.2012.05.011 · Cited by 498
A Universal Design of Betacoronavirus Vaccines against COVID-19, MERS, and SARS
Dai, L., Zheng, T., Xu, K., Han, Y., Xu, L., Huang, E., An, Y., Cheng, Y., Li, S., Liu, M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.035 · Cited by 495
Correlates and disparities of intention to vaccinate against COVID-19
Callaghan, T., Moghtaderi, A., Lueck, J. A., Hotez, P., Strych, U., Dor, A., Fowler, E. F., & Motta, M. (2021) · Social Science & Medicine · doi:10.1016/j.socscimed.2020.113638 · Cited by 494
Self-citationDevelopments in Viral Vector-Based Vaccines
Ura, T., Okuda, K., & Shimada, M. (2014) · Vaccines · doi:10.3390/vaccines2030624 · Cited by 436
Advances in aluminum hydroxide-based adjuvant research and its mechanism
He, P., Zou, Y., & Hu, Z. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2014.1004026 · Cited by 409
Kim, E., Erdos, G., Huang, S., Kenniston, T. W., Balmert, S. C., Carey, C. D., Raj, V. S., Epperly, M. W., Klimstra, W. B., Haagmans, B. L., et al. (2020) · eBioMedicine · doi:10.1016/j.ebiom.2020.102743 · Cited by 404
Understanding modern-day vaccines: what you need to know
Vetter, V., Denizer, G., Friedland, L. R., Krishnan, J., & Shapiro, M. (2018) · Annals of Medicine · doi:10.1080/07853890.2017.1407035 · Cited by 354
Xia, S., Lan, Q., Su, S., Wang, X., Xu, W., Liu, Z., Zhu, Y., Wang, Q., Lu, L., & Jiang, S. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0184-0 · Cited by 312
O’Hagan, D. T. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.5.699 · Cited by 282
Engineering complex-type N-glycosylation in Pichia pastoris using GlycoSwitch technology
Jacobs, P. P., Geysens, S., Vervecken, W., Contreras, R., & Callewaert, N. (2009) · Nature Protocols · doi:10.1038/nprot.2008.213 · Cited by 270
Effect of vaccine administration modality on immunogenicity and efficacy
Zhang, L., Wang, W., & Wang, S. (2015) · Expert Review of Vaccines · doi:10.1586/14760584.2015.1081067 · Cited by 255
Yasui, F., Kai, C., Kitabatake, M., Inoue, S., Yoneda, M., Yokochi, S., Kase, R., Sekiguchi, S., Morita, K., Hishima, T., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.9.6337 · Cited by 252
The virosome concept for influenza vaccines
Huckriede, A., Bungener, L., Stegmann, T., Daemen, T., Medema, J., Palache, A. M., & Wilschut, J. (2005) · Vaccine · doi:10.1016/j.vaccine.2005.04.026 · Cited by 250
Preparation of coated nanoparticles for a new mucosal vaccine delivery system
Borges, O., Borchard, G., Verhoef, J. C., de Sousa, A., & Junginger, H. E. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.04.037 · Cited by 240
Honda-Okubo, Y., Barnard, D., Ong, C. H., Peng, B.-H., Tseng, C.-T. K., & Petrovsky, N. (2015) · Journal of Virology · doi:10.1128/jvi.02980-14 · Cited by 210
Protein N-Glycosylation in the Baculovirus-Insect Cell System
Shi, X., & Jarvis, D. (2007) · Current Drug Targets · doi:10.2174/138945007782151360 · Cited by 197
Jones, L. S., Peek, L. J., Power, J., Markham, A., Yazzie, B., & Middaugh, C. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500687200 · Cited by 197
Correlates and Disparities of COVID-19 Vaccine Hesitancy
Callaghan, T., Moghtaderi, A., Lueck, J. A., Hotez, P. J., Strych, U., Dor, A., Franklin Fowler, E., & Motta, M. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3667971 · Cited by 197
Self-citationImmunology and efficacy of MF59-adjuvanted vaccines
Ko, E.-J., & Kang, S.-M. (2018) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2018.1495301 · Cited by 194
Tobacco, a highly efficient green bioreactor for production of therapeutic proteins
Tremblay, R., Wang, D., Jevnikar, A. M., & Ma, S. (2010) · Biotechnology Advances · doi:10.1016/j.biotechadv.2009.11.008 · Cited by 192
Development of the CpG Adjuvant 1018: A Case Study
Campbell, J. D. (2017) · Methods in Molecular Biology · doi:10.1007/978-1-4939-6445-1_2 · Cited by 189
The Mucosal Vaccine Adjuvant LT(R192G/L211A) or dmLT
Clements, J. D., & Norton, E. B. (2018) · mSphere · doi:10.1128/msphere.00215-18 · Cited by 177
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
Salvatori, G., Luberto, L., Maffei, M., Aurisicchio, L., Roscilli, G., Palombo, F., & Marra, E. (2020) · Journal of Translational Medicine · doi:10.1186/s12967-020-02392-y · Cited by 177
Recombinant Proteins for Industrial versus Pharmaceutical Purposes: A Review of Process and Pricing
Puetz, J., & Wurm, F. M. (2019) · Processes · doi:10.3390/pr7080476 · Cited by 168
COVID-19 vaccine design: the Janus face of immune enhancement
Hotez, P. J., Corry, D. B., & Bottazzi, M. E. (2020) · Nature Reviews Immunology · doi:10.1038/s41577-020-0323-4 · Cited by 168
AS03- and MF59-Adjuvanted Influenza Vaccines in Children
Wilkins, A. L., Kazmin, D. A., Napolitani, G., Clutterbuck, E., Pulendran, B., Siegrist, C., & Pollard, A. J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01760 · Cited by 167
The Lyme vaccine: a cautionary tale
NIGROVIC, L. E., & THOMPSON, K. M. (2007) · Epidemiology and Infection · doi:10.1017/s0950268806007096 · Cited by 166
Kuo, T.-Y., Lin, M.-Y., Coffman, R. L., Campbell, J. D., Traquina, P., Lin, Y.-J., Liu, L. T.-C., Cheng, J., Wu, Y.-C., Wu, C.-C., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-77077-z · Cited by 166
Protein production using the baculovirus‐insect cell expression system
Contreras‐Gómez, A., Sánchez‐Mirón, A., García‐Camacho, F., Molina‐Grima, E., & Chisti, Y. (2014) · Biotechnology Progress · doi:10.1002/btpr.1842 · Cited by 164
van den Brand, J. M. A., Haagmans, B. L., van Riel, D., Osterhaus, A. D. M. E., & Kuiken, T. (2014) · Journal of Comparative Pathology · doi:10.1016/j.jcpa.2014.01.004 · Cited by 160
S-Trimer, a COVID-19 subunit vaccine candidate, induces protective immunity in nonhuman primates
Liang, J. G., Su, D., Song, T., Zeng, Y., Huang, W., Wu, J., Xu, R., Luo, P., Yang, X., Zhang, X., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-21634-1 · Cited by 157
MF59 adjuvant: the best insurance against influenza strain diversity
O’Hagan, D. T., Rappuoli, R., Gregorio, E. D., Tsai, T. F., & Giudice, G. D. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.23 · Cited by 149
Immunization with the adjuvant MF59 induces macrophage trafficking and apoptosis
Dupuis, M., Denis-Mize, K. S., LaBarbara, A., Peters, W., Charo, I. F., McDonald, D. M., & Ott, G. S. (2001) · European Journal of Immunology · doi:10.1002/1521-4141(2001010)31:10<2910::aid-immu2910>3.0.co;2-3 · Cited by 145
Valensi, J. P., Carlson, J. R., & Nest, G. A. V. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.9.4029 · Cited by 143
Petrovsky, N., & Cooper, P. D. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.09.030 · Cited by 141
Owczarek, B., Gerszberg, A., & Hnatuszko-Konka, K. (2019) · BioMed Research International · doi:10.1155/2019/4216060 · Cited by 137
Production of Recombinant Proteins in Tobacco Guttation Fluid
Komarnytsky, S., Borisjuk, N. V., Borisjuk, L., et al. (2000) · PLANT PHYSIOLOGY · doi:10.1104/pp.124.3.927 · Cited by 127
Hotez, P. J., Bottazzi, M. E., & Corry, D. B. (2020) · Microbes and Infection · doi:10.1016/j.micinf.2020.04.005 · Cited by 125
Tseng, C.-T., Sbrana, E., Iwata-Yoshikawa, N., Newman, P. C., Garron, T., Atmar, R. L., Peters, C. J., & Couch, R. B. (2012) · PLoS ONE · doi:10.1371/annotation/2965cfae-b77d-4014-8b7b-236e01a35492 · Cited by 122
Chao, Y., Rötzschke, O., & Tan, E. (2020) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2020.05.057 · Cited by 121
Chen, W., Du, L., Chag, S., Ma, C., Tricoche, N., Tao, X., Seid, C. A., Hudspeth, E. M., Lustigman, S., Tseng, C.-T. K., et al. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.27464 · Cited by 118
Self-citationMerlin, M., Gecchele, E., Capaldi, S., Pezzotti, M., & Avesani, L. (2014) · BioMed Research International · doi:10.1155/2014/136419 · Cited by 112
Alternative Methods of Vaccine Delivery: An Overview of Edible and Intradermal Vaccines
Criscuolo, E., Caputo, V., Diotti, R. A., Sautto, G. A., Kirchenbaum, G. A., & Clementi, N. (2019) · Journal of Immunology Research · doi:10.1155/2019/8303648 · Cited by 110
Chen, W., Tao, X., Agrawal, A. S., Algaissi, A. A., Peng, B., Pollet, J. B. K., Strych, U., Bottazzi, M. E., Hotez, P. J., Lustigman, S., et al. (2020) · Vaccine · doi:10.1016/j.vaccine.2020.09.061 · Cited by 109
Self-citationCox, R. J., Pedersen, G. K., Madhun, A. S., Svindland, S. C., Sævik, M., Breakwell, L., Höschler, K., Willemsen, M., Campitelli, L., Nøstbakken, J. K., et al. (2011) · Vaccine · doi:10.1016/j.vaccine.2011.08.042 · Cited by 103
Safety of AS03-adjuvanted influenza vaccines: A review of the evidence
Cohet, C., der Most, R. G. V., Bauchau, V., Bekkat-Berkani, R., Doherty, T. M., Schuind, A., Silva, F. T. D., Rappuoli, R., Garçon, N., & Innis, B. L. (2019) · Vaccine · doi:10.1016/j.vaccine.2019.04.048 · Cited by 101
Liu, H., Su, D., Zhang, J., Ge, S., Li, Y., Wang, F., Gravel, M., Roulston, A., Qin, S., Xu, W. M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-09518-1 · Cited by 97
Pollet, J. B. K., Chen, W., Versteeg, L., Keegan, B. P., Zhan, B., Wei, J., Liu, Z., Lee, J., Kundu, R., Adhikari, R., et al. (2021) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2021.1901545 · Cited by 97
Self-citationGordon, D., Kelley, P., Heinzel, S., Cooper, P. D., & Petrovsky, N. (2014) · Vaccine · doi:10.1016/j.vaccine.2014.09.034 · Cited by 94
Liebowitz, D. N., Lindbloom, J. D., Brandl, J. R., Garg, S. J., & Tucker, S. N. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(15)00266-2 · Cited by 90
Zhao, G., Lin, Y., Du, L., Guan, J., Sun, S., Sui, H., Kou, Z., Chan, C. C. S., Guo, Y., Jiang, S., et al. (2010) · Virology Journal · doi:10.1186/1743-422x-7-9 · Cited by 90
Characteristics of a new meningococcal serogroup B vaccine, bivalent rLP2086 (MenB-FHbp; Trumenba®)
Gandhi, A. J., Balmer, P., & York, L. J. (2016) · Postgraduate Medicine · doi:10.1080/00325481.2016.1203238 · Cited by 89
Shardlow, E., Mold, M. J., & Exley, C. (2018) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-018-0305-2 · Cited by 89
COVID-19 Vaccines: “Warp Speed” Needs Mind Melds, Not Warped Minds
Moore, J. P., & Klasse, P. J. (2020) · Journal of Virology · doi:10.1128/jvi.01083-20 · Cited by 89
COVID-19 vaccines: neutralizing antibodies and the alum advantage
Hotez, P. J., Corry, D. B., Strych, U., & Bottazzi, M. E. (2020) · Nature reviews. Immunology · doi:10.1038/s41577-020-0358-6 · Cited by 84
Self-citationDeveloping a low-cost and accessible COVID-19 vaccine for global health
Hotez, P. J., & Bottazzi, M. E. (2020) · PLoS neglected tropical diseases · doi:10.1371/journal.pntd.0008548 · Cited by 83
Petrovsky, N., Larena, M., Siddharthan, V., Prow, N. A., Hall, R. A., Lobigs, M., & Morrey, J. D. (2013) · Journal of Virology · doi:10.1128/jvi.00480-13 · Cited by 81
Magnusson, S. E., Reimer, J. M., Karlsson, K. H., Lilja, L., Bengtsson, K. L., & Stertman, L. (2013) · Vaccine · doi:10.1016/j.vaccine.2013.01.039 · Cited by 78
Norton, E. B., Bauer, D. L., Weldon, W. C., Oberste, M. S., Lawson, L. B., & Clements, J. D. (2015) · Vaccine · doi:10.1016/j.vaccine.2015.02.069 · Cited by 76
Magnusson, S. E., Altenburg, A. F., Bengtsson, K. L., Bosman, F., de Vries, R. D., Rimmelzwaan, G. F., & Stertman, L. (2018) · Immunologic Research · doi:10.1007/s12026-018-8991-x · Cited by 74
Huang, M., Bao, J., & Nielsen, J. (2014) · Pharmaceutical Bioprocessing · doi:10.4155/pbp.14.8 · Cited by 68
Emerging experience with meningococcal serogroup B protein vaccines
Toneatto, D., Pizza, M., Masignani, V., & Rappuoli, R. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2017.1308828 · Cited by 67
A recombinant Lactobacillus plantarum strain expressing the spike protein of SARS-CoV-2
Wang, M., Fu, T., Hao, J., Li, L., Tian, M., Jin, N., Ren, L., & Li, C. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.05.239 · Cited by 61
SADOFF, J. C., Paepe, E. D., Haazen, W., Omoruyi, E. V. E., Bastian, A. R., Comeaux, C. A., Heijnen, E., Strout, C. B., Schuitemaker, H., & Callendret, B. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa409 · Cited by 56
MacDonald, A. J., Tawe, W., Leon, O., Cao, L., Liu, J., Oksov, Y., Abraham, D., & Lustigman, S. (2004) · Parasite Immunology · doi:10.1111/j.0141-9838.2004.00685.x · Cited by 54
Design of a highly thermotolerant, immunogenic SARS-CoV-2 spike fragment
Malladi, S. K., Singh, R., Pandey, S., Gayathri, S., Kanjo, K., Ahmed, S., Khan, M. S. A. A., Kalita, P., Girish, N., Upadhyaya, A., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra120.016284 · Cited by 53
Feinen, B., Petrovsky, N., Verma, A., & Merkel, T. J. (2014) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00019-14 · Cited by 52
Tomar, J., Patil, H. P., Bracho, G. G., Tonnis, W. F., Frijlink, H. W., Petrovsky, N., Rita Vanbever, A., Huckriede, A. L. W., & Hinrichs, W. L. J. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.09.006 · Cited by 51
Hayashi, M., Aoshi, T., Haseda, Y., Kobiyama, K., Wijaya, E., Nakatsu, N., Igarashi, Y., Standley, D. M., Yamada, H., Honda‐Okubo, Y., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.11.015 · Cited by 48
Vasan, S., Schlesinger, S. J., Huang, Y., Hurley, A., Lombardo, A. M., Chen, Z., Than, S., Adesanya, P., Bunce, C. A., Boaz, M. J., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008617 · Cited by 47
Secreted heat shock protein gp96-Ig: next-generation vaccines for cancer and infectious diseases
Štrbo, N., Garcia-Soto, A. E., Schreiber, T. H., & Podack, E. R. (2013) · Immunologic Research · doi:10.1007/s12026-013-8468-x · Cited by 45
Preparation of recombinant vaccines
Soler, É., & Houdebine, L. (2007) · Biotechnology annual review · doi:10.1016/s1387-2656(07)13004-0 · Cited by 41
Goldstein, N. H., Bockstal, V., Bart, S., Lühn, K., Robinson, C., Gaddah, A., Callendret, B., & Douoguih, M. (2020) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa586 · Cited by 40
Oberemok, V. V., Laikova, K. V., Yurchenko, K. A., Marochkin, N. A., Фомочкина, И. И., & Kubyshkin, A. V. (2020) · Inflammation Research · doi:10.1007/s00011-020-01377-3 · Cited by 39
Shirley, M., & Dhillon, S. (2015) · BioDrugs · doi:10.1007/s40259-015-0139-0 · Cited by 37
He, Y., Barker, S. J., Macdonald, A., Yu, Y., Cao, L., Li, J., Parhar, R. S., Heck, S., Hartmann, S., Golenbock, D. T., et al. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0800531 · Cited by 36
Seid, C. A., Curti, E., Jones, R. M., Hudspeth, E. M., de Rezende, W. C., Pollet, J. B. K., Lori Center, Versteeg, L., Pritchard, S., Musiychuk, K., et al. (2015) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2015.1036207 · Cited by 35
Self-citationNordén, R., Nilsson, J., Samuelsson, E., Risinger, C., Sihlbom, C., Blixt, O., Larson, G., Olofsson, S., & Bergström, T. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20040954 · Cited by 34
Heddle, R. J., Smith, A., Woodman, R. J., Hissaria, P., & Petrovsky, N. (2019) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2019.03.035 · Cited by 25
Thrane, S., Aves, K.-L., Uddback, I. E. M., Janitzek, C. M., Han, J., Yang, Y. R., Ward, A. B., Theander, T. G., Nielsen, M. A., Salanti, A., et al. (2020) · Vaccines · doi:10.3390/vaccines8030389 · Cited by 23
Induction of SARS-CoV-2 Protein S-Specific CD8+ T Cells in the Lungs of gp96-Ig-S Vaccinated Mice
Fisher, E., Padula, L., Podack, K., O’Neill, K. E., Seavey, M. M., Jayaraman, P., Jasuja, R. R., & Štrbo, N. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2020.602254 · Cited by 19
Pearson, M. S., Jariwala, A. R., Abbenante, G., Plieskatt, J. L., Wilson, D. T. R., Bottazzi, M. E., Hotez, P. J., Keegan, B. P., Bethony, J. M., & Loukas, A. C. (2015) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.980199 · Cited by 17
Evaluation of potential immunogenicity differences between Pandemrix™ and Arepanrix™
Canelle, Q., Dewé, W., Innis, B. L., & der Most, R. G. V. (2016) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2016.1168954 · Cited by 14
Molecular clamp stabilised Spike protein for protection against SARS-CoV-2Preprint
Watterson, D., Wijesundara, D. K., Modhiran, N., Mordant, F. L., Li, Z., Avumegah, M. S., McMillan, C. L. D., Lackenby, J. A., Guilfoyle, K. A., van Amerongen, G., et al. (2020) · doi:10.21203/rs.3.rs-68892/v1 · Cited by 14
Honda‐Okubo, Y., Rajapaksha, H., Sajkov, D., Gordon, D., Cox, M. M. J., & Petrovsky, N. (2017) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2017.1279765 · Cited by 9
Chen, W.-H., Wei, J., Kundu, R. T., Adhikari, R., Liu, Z., Lee, J., Versteeg, L., Poveda, C., Keegan, B., Villar, M. J., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.09.373449 · Cited by 7
Self-citation
Cited by
Cancer vaccines as promising immuno-therapeutics: platforms and current progress
Liu, J., Fu, M., Wang, M., Wan, D., Wei, Y., & Wei, X. (2022) · Journal of Hematology & Oncology · doi:10.1186/s13045-022-01247-x · Cited by 715
COVID-19 vaccine development: milestones, lessons and prospects
Li, M., Wang, H., Tian, L., Pang, Z., Yang, Q., Huang, T., Fan, J., Song, L., Tong, Y., & Fan, H. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00996-y · Cited by 434
Azali, M. A., Mohamed, S., Harun, A., Hussain, F. A., Shamsuddin, S., & Johan, M. F. (2022) · Journal of Genetic Engineering and Biotechnology · doi:10.1186/s43141-022-00368-7 · Cited by 13
Metadata
- Authors
- Pollet, J., Chen, W.-H., & Strych, U.
- Venue
- Advanced Drug Delivery Reviews
- Publisher
- Elsevier BV
- Published
- 2021-03
- Volume
- 170
- Pages
- 71-82
- ISSN
- 0169-409X (ISSN-L)
- OpenAlex
- W3107751762
- Cited by
- 277
- References
- 113
- FWCI
- 7.38
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.